The Spectrum of MDS: Disease Management and Patient Education ~ 1.5 CNE

The Spectrum of MDS: Disease Management and Patient Education

Description

The symposium was presented through the ONS Congress Virtual platform on Thursday, April 29th, 2021, and is targeted to clinical nursing professionals in oncology. Topics include the latest developments in diagnosing and treating low-risk MDS, high-risk MDS, and secondary AML; clinical trial participation; disease management for chronic anemia, side effects, and treatment adherence; psychosocial considerations and palliative care to improve the quality of life for this patient population. Case studies are used to illustrate treatment decision-making and therapeutic challenges.

Educational Objectives

After completing this accredited CE activity, the participant should be better able to:

· Explain the methods used to diagnose, stratify and treat MDS

· Identify current and emerging treatment options for patients with low-risk MDS, high-risk MDS, and secondary AML

· Analyze the nurse's role in managing treatment for MDS based on clinical presentations, diagnostic workups, transfusion dependence, comorbidities, and clinical trial consideration

· Discuss strategies to address treatment goals and decision-making, educate patients and provide palliative care to improve outcomes

Presenters:

- Catherine Chittick, RN, BSN, BMT/Leukemia Staff,

Massachusetts General Hospital Cancer Center, Boston, MA

- Jenna Moran, MSN, FNP-BC, Leukemia Team,

Massachusetts General Hospital Cancer Center, Boston, MA

- Aura Ramos, RN, BSN, Leukemia Team,

Massachusetts General Hospital Cancer Center, Boston, MA

Start the Program Here

Target Audience

This accredited CE activity is intended for nurses and nurse practitioners engaged in the care of patients with bone marrow failure disease.

Accreditation, Credit, and Support

This activity is developed with our educational partner Aplastic Anemia and MDS International Foundation.

This accredited CE activity is supported by independent educational grants from Bristol Myers Squibb and Gilead Sciences, Inc.

Nursing Continuing Professional Development (NCPD)

Medical Learning Institute, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Successful completion of this nursing continuing professional development activity will be awarded 1.5 contact hours and 1.12 contact hours in the area of pharmacology.

Nurse Practitioner Credit Designation (AANP)

This activity is approved for 1.5 contact hour(s) of continuing education (which includes 0.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 21054933. This activity was planned in accordance with AANP Accreditation Standards and Policies.